Search research articles
Contact Us
Filters
Showing results (771-780 of 1,171) with videos related to
Page
of 118
Sort By:
Psychiatric Services (Washington, D.C.)
|
April 2, 2026
Pathways to Mental Health Care: The Role of Religion and Spirituality in Help Seeking for Psychosis
Leena Badran, Tara Niendam, Daniel I Shapiro, et al.
Annals of Emergency Medicine
|
June 18, 2026
Improving End-of-Life Screening in the Emergency Department With Collaborative Artificial Intelligence
Adrian D Haimovich, Gabriel Erion-Barner, Larry A Nathanson, et al.
Cancer Research
|
August 16, 2022
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers
Jeffrey Patterson-Fortin, Arindam Bose, Wei-Chih Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2013
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors
Geoffrey I Shapiro, Jordi Rodon, Cynthia Bedell, et al.
Iscience
|
November 10, 2021
Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
Komal Sodhi, Rebecca Pratt, Xiaoliang Wang, et al.
Iscience
|
December 4, 2023
Erratum: Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
Komal Sodhi, Rebecca Pratt, Xiaoliang Wang, et al.
Kidney International
|
April 21, 2005
Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells
Sankaridrug M Periyasamy, Jiang Liu, Feras Tanta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2021
Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors
Khanh T Do, Bose Kochupurakkal, Sarah Kelland, et al.
Shock (Augusta, Ga.)
|
January 20, 2012
Adiponectin diminishes organ-specific microvascular endothelial cell activation associated with sepsis
Matijs van Meurs, Pedro Castro, Nathan I Shapiro, et al.
Investigational New Drugs
|
November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan
James M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Page
of 118
Search research articles
Search
Showing results (771-780 of 1,171) with videos related to
Sort By:
Page
of 118
Psychiatric Services (Washington, D.C.)
|
April 2, 2026
Pathways to Mental Health Care: The Role of Religion and Spirituality in Help Seeking for Psychosis
Leena Badran, Tara Niendam, Daniel I Shapiro, et al.
Annals of Emergency Medicine
|
June 18, 2026
Improving End-of-Life Screening in the Emergency Department With Collaborative Artificial Intelligence
Adrian D Haimovich, Gabriel Erion-Barner, Larry A Nathanson, et al.
Cancer Research
|
August 16, 2022
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers
Jeffrey Patterson-Fortin, Arindam Bose, Wei-Chih Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2013
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors
Geoffrey I Shapiro, Jordi Rodon, Cynthia Bedell, et al.
Iscience
|
November 10, 2021
Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
Komal Sodhi, Rebecca Pratt, Xiaoliang Wang, et al.
Iscience
|
December 4, 2023
Erratum: Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
Komal Sodhi, Rebecca Pratt, Xiaoliang Wang, et al.
Kidney International
|
April 21, 2005
Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells
Sankaridrug M Periyasamy, Jiang Liu, Feras Tanta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2021
Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors
Khanh T Do, Bose Kochupurakkal, Sarah Kelland, et al.
Shock (Augusta, Ga.)
|
January 20, 2012
Adiponectin diminishes organ-specific microvascular endothelial cell activation associated with sepsis
Matijs van Meurs, Pedro Castro, Nathan I Shapiro, et al.
Investigational New Drugs
|
November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan
James M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Page
of 118